Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Short term Debt (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Short term Debt for 15 consecutive years, with $574.6 million as the latest value for Q2 2025.

  • Quarterly Short term Debt rose 2272.63% to $574.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $574.6 million through Jun 2025, up 2272.63% year-over-year, with the annual reading at $33.9 million for FY2024, N/A changed from the prior year.
  • Short term Debt hit $574.6 million in Q2 2025 for Integra Lifesciences Holdings, roughly flat from $573.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $574.6 million in Q2 2025 to a low of $4.8 million in Q2 2023.
  • Historically, Short term Debt has averaged $102.5 million across 5 years, with a median of $45.0 million in 2021.
  • Biggest five-year swings in Short term Debt: tumbled 90.43% in 2023 and later surged 2862.06% in 2025.
  • Year by year, Short term Debt stood at $45.0 million in 2021, then dropped by 15.28% to $38.1 million in 2022, then crashed by 74.59% to $9.7 million in 2023, then soared by 250.02% to $33.9 million in 2024, then soared by 1594.77% to $574.6 million in 2025.
  • Business Quant data shows Short term Debt for IART at $574.6 million in Q2 2025, $573.9 million in Q1 2025, and $33.9 million in Q4 2024.